Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Latest, FY2025
417
Period ended Dec 31, 2025
Change on a year earlier
+18.8%
351 in FY2024
History
19 years
Since FY2007
Sources
17
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Short-Term Investments ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 417 | +18.8% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 351 | -8.4% | Form 10-K (filed 2025-02-21) ↗ |
| FY2023 | Dec 31, 2023 | 383 | +33.0% | Form 10-K (filed 2024-02-16) ↗ |
| FY2022 | Dec 31, 2022 | 288 | -36.0% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 450 | +45.2% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 310 | +10.7% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 280 | +15.7% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 242 | +19.2% | Form 10-K (filed 2019-02-22) ↗ |
| FY2017 | Dec 31, 2017 | 203 | +31.0% | Form 10-K (filed 2018-02-16) ↗ |
| FY2016 | Dec 31, 2016 | 155 | -86.2% | Form 10-K (filed 2017-02-17) ↗ |
| FY2015 | Dec 31, 2015 | 1,124 | +183.1% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 397 | -91.4% | Form 10-K (filed 2015-02-27) ↗ |
| FY2013 | Dec 31, 2013 | 4,623 | +5.7% | Form 10-K (filed 2014-02-21) ↗ |
| FY2012 | Dec 31, 2012 | 4,372 | +240.2% | Form 10-K (filed 2014-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 1,285 | -28.7% | Form 10-K (filed 2012-02-21) ↗ |
| FY2010 | Dec 31, 2010 | 1,803 | +60.6% | Form 10-K (filed 2011-02-18) ↗ |
| FY2009 | Dec 31, 2009 | 1,123 | +16.0% | Form 10-K (filed 2010-02-19) ↗ |
| FY2008 | Dec 31, 2008 | 968 | +165.9% | Form 10-Q (filed 2009-08-07) ↗ |
| FY2007 | Dec 31, 2007 | 364 | – | Form 10-K (filed 2010-02-19) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Short-Term Investments ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-bs-st-inv
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.